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The long bones of vertebrate limbs originate from cartilage templates and are formed by the process of endochondral ossification. This process
requires that chondrocytes undergo a progressive maturation from proliferating to postmitotic prehypertrophic to mature, hypertrophic
chondrocytes. Coordinated control of proliferation and maturation regulates growth of the skeletal elements. Various signals and pathways have
been implicated in orchestrating these processes, but the underlying intracellular molecular mechanisms are often not entirely known. Here we
demonstrated in the chick using replication-competent retroviruses that constitutive activation of Calcium/Calmodulin-dependent kinase II
(CaMKII) in the developing wing resulted in elongation of skeletal elements associated with premature differentiation of chondrocytes. The
premature maturation of chondrocytes was a cell-autonomous effect of constitutive CaMKII signaling associated with down-regulation of cell-
cycle regulators and up-regulation of chondrocyte maturation markers. In contrast, the elongation of the skeletal elements resulted from a non-cell
autonomous up-regulation of the Indian hedgehog responsive gene encoding Parathyroid-hormone-related peptide. Reduction of endogenous
CaMKII activity by overexpressing an inhibitory peptide resulted in shortening of the skeletal elements associated with a delay in chondrocyte
maturation. Thus, CaMKII is an essential component of intracellular signaling pathways regulating chondrocyte maturation.
© 2008 Elsevier Inc. All rights reserved.Keywords: Chicken; Chondrocyte maturation; Cyclin; AP1; PTHrP-signalingIntroduction
The vertebrate skeleton is a complex structure with over 200
skeletal elements, which differ in shape and size. The majority
of skeletal elements are formed by endochondral ossification,
whereby a cartilaginous scaffold that prefigures the future
skeletal element is eventually replaced by bone. Chondrocytes
within these cartilaginous scaffolds have to undergo a highly
regulated maturation process that controls the size of the future
element and is absolutely required for the remodeling into bone.
During maturation chondrocytes cease to proliferate, become
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doi:10.1016/j.ydbio.2008.02.007further into hypertrophic chondrocytes. Various growth factors
and hormones are involved in the regulation of chondrocyte
maturation (Church et al., 2002; Karsenty and Wagner, 2002;
Yasoda et al., 2004), yet little is known about the intracellular
signaling pathways involved.
Many of the so far known pathways seem to feed into a
central regulatory negative feedback loop between the secreted
molecules Indian hedgehog (Ihh) and Parathyroid-related
peptide (PTHrP) coordinating chondrocyte proliferation and
maturation (Kronenberg, 2003). This feedback loop is con-
served in different species such as chicken, mouse and humans.
Ihh is synthesized by prehypertrophic chondrocytes and
regulates the expression of Pthrp by periarticular chondrocytes
(Lanske et al., 1996; St-Jacques et al., 1999; Vortkamp et al.,
1996). Ihh has PTHrP-dependent and independent effects on
chondrocyte maturation; it acts through PTHrP to keep
chondrocytes in the proliferative pool and controls chondrocyte
proliferation independent of PTHrP (Chung et al., 1998; Karp et
al., 2000; Long et al., 2001). PTHrP as well as the calcium
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protein coupled PTH/PTHrP-receptor (Ppr). Ppr is expressed at
low levels by proliferating chondrocytes and at high levels by
prehypertrophic and early hypertrophic chondrocytes. PTHrP/
Ppr signaling is important in controlling chondrocyte prolifera-
tion and maturation; high levels of PTHrP, or constitutive PPR
signaling, delay the appearance of maturated, hypertrophic
chondrocytes, while loss of PPR signaling results in shortening
of long bones and accelerated chondrocyte maturation (Lanske
et al., 1999; Schipani et al., 1997; Weir et al., 1996). PPR signals
via heterotrimeric G-proteins such as Gs, which stimulates
adenylyl cyclase or Gq/11, which activates phospholipase C
(PLC), thereby generating multiple second messengers (Abou-
Samra et al., 1992; Guo et al., 2002; Juppner et al., 1991). Gs
signaling leads to activation of cAMP-dependent protein kinase
A (PKA) and is required to keep chondrocytes in the
proliferative pool (Bastepe et al., 2004). In contrast, PPR
signaling via Gq/11 and PLC stimulates chondrocyte maturation
(Guo et al., 2002). Thus, activation of different intracellular
pathways downstream of PPR plays a critical role in
determining the rate of chondrocyte maturation during endo-
chondral ossification.
PLC-signaling leads to the activation of different protein
kinases such as protein kinase C (PKC) and Calcium/
Calmodulin (CaM) dependent kinases (CaMKs) including
CaMKIIs. Four different CaMKII genes have been reported in
vertebrates, encoding the four isoforms, CaMKII α, β, γ, δ,
with numerous splice-variants. CaMKII acts as a multimeric
holoenzyme composed out of 4–14 subunits of either homo- or
heteromers (Lantsman and Tombes, 2005; Rosenberg et al.,
2006). Ca2+/CaM binding leads to Thr286-autophosphorylation
and releases the enzyme from autoinhibition, rendering it in a
Ca2+/CaM independent active form (Colbran, 2004; Hudmon
and Schulman, 2002). CaMKII has been shown to play
important roles in synaptic plasticity and memory (Cammarota
et al., 2002; Fox, 2003). In addition, CaMKII signaling has been
implicated in mediating mechanical transduction in human and
bovine articular cartilage (Shimazaki et al., 2006; Valhmu and
Raia, 2002) and in osteoblast and osteoclast differentiation
(Quinn et al., 2000; Seales et al., 2006; Zayzafoon, 2006; Zhang
et al., 2005).
Since CaMKII is activated downstream of PLC and all four
isoforms are expressed in chicken chondrocytes, its activity
could potentially be involved in various signaling pathways,
such as the PTHrP/PPR, FGF or the non-canonical Wnts, which
are known to regulate chondrogenesis. In order to gain insight
into a potential role of CaMKII in skeletogenesis we used a
retroviral misexpression approach in chicken. Constitutive
activation of CaMKII signaling in the developing limb using
a retrovirus expressing the mutated CaMKII-T286D form
(daCaMKII) resulted in skeletal overgrowth of infected long
bones and premature maturation of chondrocytes. In contrast
inhibition of endogenous CaMKIIs using retroviral-mediated
overexpression of a peptide-inhibitor resulted in shortening of
the infected long bones. Thus, our results suggest that intra-
cellular CaMKII activity is involved in the control of chon-
drocyte maturation.Materials and methods
Construction of retroviruses and retroviral misexpression
The retroviral constructs RCASBP(A) carrying the ORF of the rat
CamkIIα gene with the point mutation T286D, rendering the CaMKII
constitutively active, or K42M, converting it to a kinase-dead molecule (Kuhl
et al., 2000), as well as the viruses carrying the corresponding eGFP fusion
proteins (eGFP was fused in frame with the ORF of CaMKII-T286D and
CaMKII-K24M via an BamHI site located in a short linker at the 5′end of
the eGFP gene) were engineered as outlined in (Logan and Tabin, 1998). The
RCASBP(A) expressing the a fusion of eGFP and the rat CaM-KIIN fusion-
protein (gift from T. Soderling) was generated by PCR and cloning of the
GFP-CaM-K2N (NcoI–HindIII) into the Slax13 shuttle vector. Transfection
and growth of the RCAS viruses were performed in principle according to
(Morgan and Fekete, 1996) with slight modifications. Concentrated viruses
with a titer of 0.8–1.0×109 pfu/ml were injected as described previously
(Hartmann and Tabin, 2000).
Skeletal preparations, histology, in situ hybridization and
immunohistochemistry
Whole mount alcian blue stainings of days 8.5 and 9.5 chick embryos were
performed as previously described (Goff and Tabin, 1997). Weigert–Safranin O
and alcian blue stainings of paraffin sections were done according to standard
procedures. Non-radioactive in situ hybridizations on alternating paraffin
sections of blocks containing both the contra-lateral wing and the infected wing
were done using DIG-labeled anti-sense RNA probes as previously described
(Murtaugh et al., 2001). Double fluorescent in situ-hybridizations were done
using DIG- and Biotin-labeled RNA probes modified after (Tylzanowski et al.,
2003). Briefly after hybridization, slides were washed, quenched and blocked.
Probes were then detected sequentially by incubation of slides with
streptavidine-HRP (Perkin Elmer, dilution 1 in 100) developed with Cy3 or
Cy5 tyramide labelled fluorescent dyes, followed by a quenching step with
streptavidine solution (Roche, dilution 1 in 75) and subsequent detection of the
DIG labeled probe using anti-DIG-HRP (Roche, dilution 1 in 50), followed by
Cy5 or Cy3 tyramide labelled fluorescent dyes (see also instructions of the TSA
plus fluorescent systems kit, Perkin Elmer, NEL760). Tissue was mounted in
using SlowFade Light Antifade (Molecular Probes). Chicken probes for Ihh,
ColX, Pthrp, and Ppr have been published previously. Probes for c-Fos (ChEST
517o21) and c-Jun (ChEST 947b5) were generated from UMIST clones. Probes
for cyclinA (for: CAGCTCCGACGATCAACC; rev: TCAGACTTGGTCTT-
CATGG) and cyclinD1 (for: GACCCGACGAGTTACTGC; rev:
GATTCCTTCTCAGATGCCC) were generated by RT-PCR using the indicated
primer pairs and cloned into pGEMTeasy (Promega).
Cell culture and cell sorting
Primary chondrocytes were isolated from E18.5 chicken as previously
described (Koyama et al., 1999), using the caudal 1/3 of the sternum to enrich
for proliferating chondrocytes. Chondrocytes were cultures at 5×105 cells per
well in a 6-well plate. Chondrocytes were infected at 50–60% confluence with
2×106 viral particles in 500 μl medium. Infection of chondrocytes was
determined by immunohistochemical staining using 1:3 diluted 3C2 hybridoma
cell supernatant (Developmental Studies Hybridoma Bank). Gfp-virus infected
cells were FACS sorted for GFP 2 days post infection and plated for one extra
day prior to RNA or protein isolation. For the in vitro studies at least three
independent experiments were carried out.
Northern blot and Real-time PCR analyses
RNA from cultured primary chondrocytes or freshly isolated sterna was
isolated using TRIZOL according to manufacturers instructions. 15 μg total
RNA/lane were used for Northern blot analysis following standard protocols.
[P32]-labeled probes for CamkIIα, β, γ, and δ were generated using the
rediprime kit (Amersham) and inserts of the appropriate UMIST EST clones
(ChEST 141m12; ChEST 712p21; ChEST 213l23) or from a PCR product (for:
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cloned into pGEMT in the case of CamkIIβ. For Real time PCR analysis
1 μg of DNase treated, total RNAwas used to produce first strand cDNA. Real
time PCR was performed using SYBR green 1 nucleic acid gel stain (Molecular
Probes), TAKARA Taq, and the DNA-engine Opticon 2 (MJ Research). Real
time PCR analyses were performed in duplicates and results were reproduced in
three independent experiments. Values were calculated using the comparative C
(t) method, and normalized to cGapdh expression. Primer sequences are
available by request. P-values were determined by performing a paired Student
t-test.Results
Expression of CaMKII isoforms in chick chondrocytes
CamkIIs are more or less ubiquitously expressed, however,
some isoforms are more prevalent in certain tissues, for example
CamkIIα and β are very abundant in the brain, while the γ and
δ-isoforms are more broadly expressed (Rongo, 2002; Soder-
ling et al., 2001). In the chicken, we detected all four isoforms,
α, β, γ, δ, by RT-PCR and Northern blot in primary
chondrocytes (Fig. 1A; data not shown). We confirmed the
presence of the γ, δ isoforms byWestern blots (data not shown).
However, we were unable to detect any specific expression
patterns for the different isoforms within the cartilage elements
by in situ hybridization.
Constitutive activation of CaMKII results in skeletal
overgrowth
We performed retroviral misexpression experiments using
replication competent avian retroviruses (RCAS) to analyze a
potential role of CaMKII signaling in chondrogenesis. Since
CaMKII acts as multimeric holoenzyme, which can be
composed of different isoforms, we used a retrovirus
expressing a constitutively active form of one CaMKII isoform
(CaMKIIα-T286D; Hanson et al., 1994), referred to in the
following as daCaMKII, to transform the entire holoenzyme
into a dominant active complex through incorporation of one
to two dominant-active subunits (Hudmon and Schulman,
2002). Misexpression of daCaMKII in the posterior half of
chicken wing buds at day 3.5 (HH22–23) resulted in aFig. 1. Phenotypic changes in response to retroviral daCaMKII overexpression. (A) R
(B–C) Alcian blue stained whole skeletal preparations of wing pairs at d9.5; the low
served as the internal control. The black bars and the numbers indicate the length of th
infected with RCAS-daCaMKII shows elongation of the skeletal elements, such as
relative increase in length of infected R-ulnae (orange bar) in comparison to the contr
represents the standard deviation of the mean of the results. (C) RCAS-kdCaMKI
comparison to contra-lateral wing. Bar diagram showing no difference in the relative l
(black bar), n=10. (D–K) Histological and in situ analyses on sections of uninfected
(D–E) Low magnification of a contra-lateral uninfected wing, showing the radius (up
(D) indicates the length of the proliferating zone in the uninfected ulna in comparison
shown in (E), the broken lines demarcate the zone of hypertrophic chondrocytes.
magnification of the infected ulna showing a localized expansion of hypertrophic ce
showing no infection in chondrocytes in the contra-lateral ulna (H), but high levels o
ectopic differentiation into hypertrophic chondrocytes correlates in part with the infe
showing the orderly array of flattened proliferating chondrocytes in the contra-latera
vacuolized (appear white) cells (K).noticeable lengthening of the infected skeletal elements at days
8.5 and 9.5 by 6–14% compared to corresponding elements in
the contra-lateral wing (n=20, Fig. 1B, and data not shown).
The lengthening of the infected elements upon misexpression
of daCaMKII is a very peculiar phenotype, since misexpres-
sion of various factors commonly leads to shortening of the
affected elements.
In addition, we misexpressed a RCAS virus encoding a
CaMKII subunit with a K24M mutation in the ATP-binding
pocket (kdCaMKII), which did not affect the growth of the
infected skeletal elements (n=9; Fig. 1C). This result was not
entirely unexpected since retroviral mediated expression levels
are probably insufficient to replace all subunits and replacement
of only some of the subunits of the holoenzyme with a kinase-
dead molecule will not render the enzyme inactive (Rich and
Schulman, 1998).
CaMKII signaling causes premature differentiation of
chondrocytes
We next examined why the daCaMKII infected skeletal
elements were elongated, performing histological and marker
gene analyses at various stages of development. The histolo-
gical analyses on sections of infected and uninfected (contra-
lateral control limbs) using Safranin O/Weigert revealed an
ectopic expansion of enlarged, vacuolized, hypertrophic
chondrocytes into the prehypertrophic region (Figs. 1E, G)
compared to wild-type skeletal elements (Figs. 1D, F). The
expansion of hypertrophic chondrocytes overlapped in part with
the infected regions, detected by in situ hybridization using an
anti-sense probe for the exogenous rat CamkII transcript
(compare yellow encircled regions Figs. 1G, I). In addition, a
slight elongation of the zone of round and flattened proliferative
chondrocytes (from the articular region to the endogenous zone
of hypertrophic chondrocytes) was observed in the infected
skeletal elements (white line in Fig. 1E, compared to black line
in Fig. 1D). Alcian-blue staining on infected and control limbs
revealed the presence of abnormal looking, enlarged cells
within the zone of flattened proliferative chondrocytes in
infected elements (compare Figs. 1K, J). In all samples analyzed
no retroviral infection was detected in chondrocytes of skeletalT-PCR for CaMKII-isoforms, α, β, γ, δ, and HPRT as control on dilution series.
er, right (R) wing was virally infected and the upper, contra-lateral left (L) wing
e ulnae; note length of the uninfected L-wing is always set to one. (B) Right wing
the ulna, in comparison to the contra-lateral element. Bar diagram showing the
a-lateral L-ulnae (black bar), n=20, pb0.00005 (paired Student t-test), error bar
I infected wing shows no size difference in the length of skeletal elements in
ength of infected R-ulnae (orange bar) in comparison to the contra-lateral L-ulnae
and infected ulnae at day 9.5 (D–I) and day 12.5 (J–K), showing the distal ends.
per) and ulna (lower) elements stained with Safranin O-Weigert. The black bar in
to the white bar indicating the length of the proliferation zone in the infected ulna
(F) Higher magnification of the distal end of the uninfected ulna. (G) Higher
lls (area demarcated by yellow line). (H–I) In situ hybridization for rat CamkII
f patchy infection in chondrocytes in the ulna of the infected limb (I). Note the
cted regions (area demarcated in yellow). (J–K) Alcian blue staining on sections
l ulna (J), which is disturbed in the infected ulna by the appearance of enlarged,
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muscles and dermis was observed due to the spreading of the
virus through the vascular system (see Fig. 1H). No changes
were observed in skeletal elements infected with the RCAS-
kdCaMKII virus (data not shown).
Molecular marker analyses by in situ hybridization on
alternating sections from day 7.5–11.5 old wings revealed that a
subset of the infected cells (Figs. 2B, H), located within the zoneof proliferating chondrocytes, ectopically expressed Ihh, a
marker for prehypertrophic chondrocytes (arrows in Fig. 2D,
black circled and red boxed region in Fig. 2J; and data not
shown). Similarly, a subset of infected cells ectopically
expressed Collagen X (ColX), a marker for hypertrophic
chondrocytes (arrows in Fig. 2F, and red boxed region in Fig.
2L). Interestingly, analogous to the wild-type showing nested
expression domains of Ihh and ColX, ectopic Ihh positive cells
Fig. 2. DaCaMKII misexpression causes premature chondrocyte maturation. (A–N) Non-radioactive in situ hybridizations on alternating sections of contra-lateral and
RCAS-daCaMKII infected wings at day 7.5 (A–F) and day 9.5 (G–N). (A) Absence of ectopic CamkIIα expression in chondrocytes of the contra-lateral, uninfected
ulna. (B) Ectopic CamkII expression in the infected ulna. (C) Ihh expression in contra-lateral, uninfected ulna. (D) Presence of ectopic Ihh-positive cells closer to the
articular region (arrows) in the infected ulna. (E) ColX expression domain in contra-lateral, uninfected ulna (black bar). (F) Presence of ectopic ColX-positive cells in
the infected ulna (arrows). The red bar in (E) and (F) indicates the size of the ColX expression domain, not including the region in which ectopic differentiation is
observed. (G) Absence of exogenous CamkII in the contra-lateral ulna. (H) Ectopic CamkII expression in the infected ulna. (I) Wild-type expression of Ihh. (J)
Presence of ectopic Ihh positive cells in the zone of proliferating chondrocytes (red square and black circle). (K) Wild-type ColX expression in hypertrophic
chondrocytes. (L) Ectopic ColX expression within the zone of proliferative chondrocytes (red square), however, cells closer to the articular region do not show ectopic
ColX expression (black circle). (M, N) Pthrp expression in the articular region of the contra-lateral, uninfected ulnae and of the infected ulnae, showing increased
expression levels of Pthrp in the articular region of the infected ulnae (asterisk).
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Fig. 2J), while ectopic ColX positive cells were detected in
regions closer to the diaphysis (red box in Fig. 2L).
Furthermore, analysis of ColX at day 7.5 revealed a rather
unexpected reduction in the size of the ColX domain in the
infected skeletal elements in comparison to the control elements
(see red brackets in Figs. 2E, F compared to black bracket in
Fig. 2E). This size reduction is indicative for a delay in thematuration of hypertrophic chondrocyte. Thus activation of
CaMKII signaling leads to an overall elongation of the infected
skeletal elements associated with ectopic maturation of infected
chondrocytes within the proliferative zone, while at the same
time the size of the endogenous zone of hypertropic, ColX
expressing chondrocytes was reduced in the infected elements
suggesting an overall delay in chondrocyte maturation. These
partially contradictory observations suggest that CaMKII
137M.J. Taschner et al. / Developmental Biology 317 (2008) 132–146signaling must lead to the production of secondary signals
involved in proliferation and negative regulation of chondrocyte
maturation, one of them being Ihh.
We hypothesized that the presence of cells ectopically
expressing Ihh closer to the articular region should lead to an
up-regulation of Pthrp expression in articular chondrocytes.
Therefore, we performed in situ hybridizations using a Pthrp
riboprobe and found that Pthrp was indeed up-regulated in
articular chondrocytes of the elbow region in the infected (Fig.
2N), compared to the contra-lateral limbs (Fig. 2M). The marker
analyses on alternating sections suggested that the ectopic
expression of maturation markers always coincided with
daCaMKII infected areas, but we could not rule out the
possibility that CaMKII signaling up-regulated a secreted
molecule stimulating maturation of surrounding cells. To
unambiguously show in vivo that the ectopic maturation of
chondrocytes was a cell-autonomous event down-stream of
CaMKII signaling, we performed double-fluorescence in situ
hybridizations for CamkII/Ihh (Figs. 3A–C) and CamkII/ColX
(Figs. 3D–F). Cells ectopically expressing Ihh always coloca-
lized with daCaMKII expressing cells (see arrows in Figs. 3A,
B) and cells ectopically expressing ColX also colocalize with
daCaMKII positive cells (see arrows in Figs. 3D, E). However,Fig. 3. Cell autonomous maturation of daCaMKII-infected cells. (A–F) Double fluor
detected with Cy3 using a digoxygenin-labeled anti-sense riboprobe. (B, E) Ectopic
(C) Merged image of Ihh in red and CamkII in green. (D) Cy3 channel showing ColX
in red and CamkII in green. Note: yellow arrows mark cells expressing ectopicallylike in the non-fluorescent in situ hybridizations, not every
CaMKII positive cell expressed Ihh or ColX. These results
demonstrate that the ectopic maturation is a cell-autonomous
event, since it occurred only in chondrocytes where the CaMKII
signaling pathway had been activated. Nevertheless, these
observations do not rule out that the ectopic up-regulation of
maturation markers is still under the influence of extrinsic
signals, which would explain why not all cells expressing
daCaMKII ectopically maturated, especially those closest to the
articular region.
Down-regulation of cyclins and AP1 family members precedes
ectopic maturation of chondrocytes
The finding that mature chondrocytes, which express Ihh
and ColX, are found closer to the articular region, resembles the
phenotypes of Ppr−/− and Gnas−/− (encoding Gαs) chimeric
growth plates, where chondrocytes lacking either PPR or the
Gαs subunit of heterotrimeric G-proteins ectopically mature
into hypertrophic chondrocytes (Bastepe et al., 2004; Chung et
al., 1998). Since CyclinA and CyclinD1, as well as c-Fos and c-
Jun have been shown to be regulated by PPR signaling (Beier
and LuValle, 2002; Ionescu et al., 2001) we analyzed theescent hybridizations on daCaMKII infected ulnae at day 10. (A) Ihh expression
CamkII expression detected with Cy5 using a biotinylated anti-sense riboprobe.
expression using a DIG-labeled anti-sense riboprobe. (F) Merged image of ColX
Ihh (A) or ColX (D) and are infected with daCaMKII (B, E).
Fig. 4. CaMKII signaling causes down-regulation of the cell-cycle genes cyclinA andD1. (A–R)Double fluorescent hybridizations on sections of the contra-lateral ulna
(A, D, G, J,M, P) of daCaMKII-infected specimens (B, E, H, K, N, Q), and of kdCaMKII-infectedwings at day 9.5, showing the distal end of the ulnae. (A–C) Black and
white images of Cy5 channel showing absence of infection in chondrocytes of the contra-lateral element (A) and ectopicCamkII expression in infected elements (B, C).
(D–F) Black and white images of the Cy3 channel showing ubiquitous CyclinA expression in proliferating chondrocytes in wild-type (D) and kdCaMKII-infected
elements (F), and patchy down-regulation in daCaMKII-infected elements (yellow encircled areas in panel E), using a digoxygenin-labeled anti-sense riboprobe. (G–I)
Merged images showing CamkII in red and CyclinA in green. (J–L) Cy5 channel showing absence of infection in the contra-lateral element (J) and detecting ectopic
CamkII expression in infected elements (K, L) using a biotinylated anti-sense riboprobe. (M–O) Cy3 channel showing CyclinD1 expression in the wild-type (J) being
highest in a subpopulation of proliferating chondrocytes (zone II, see panels M, P) using a digoxygenin-labeled anti-sense riboprobe. (N) Patchy down-regulation of
CyclinD1 in daCaMKII-infected elements (yellow encircled areas in panel N) and increase in CyclinD1 in uninfected chondrocytes of zone I (see asterisk in panels N,
Q). (O) No alterations were detected kdCaMKII-infected elements. (P–R) Merged images showing CamkII in red and CyclinD1 expression in green.
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infected skeletal elements using double-fluorescence in situ
hybridizations. The kdCaMKII infected elements served as a
control for possible quenching effect of the probe detecting the
infected areas on the second fluorescent signal. CyclinA in the
contra-lateral wing, which showed no exogenous CaMKII-
signal (Fig. 4A), was more or less ubiquitously expressed in
proliferating chondrocytes (Fig. 4D). In contrast its expression
was down-regulated (Fig. 4E) in regions that were infected with
RCAS-daCaMKII (Fig. 4B). No apparent expression changes
were detected in kdCaMKII infected chondrocytes (Figs. 4C, F),
showing that the down-regulation was not due to a quenching of
the second signal. CyclinD1 was expressed in wild-type skeletal
elements at low levels in chondrocytes close to the articular
region (region I), while its expression was then up-regulated
(region II) and went down again as chondrocytes matured
(region III) (Figs. 4M, P). A similar expression profile has been
reported for the CyclinD1 protein (Yang et al., 2003). In contrast
to the controls, we observed in the infected elements that Cy-
clinD1 expression in region I was elevated in cells that were not
infected with the daCaMKII virus (see asterisks in Figs. 4N, Q),
while its expression was down-regulated (Fig. 4N) in daCaMKII
infected proliferating chondrocytes (Fig. 4K). No such changes
were observed in kdCaMKII infected chondrocytes (Figs. 4L,
O). Expression of c-Fos and c-Jun, which are ubiquitously ex-
pressed in proliferating chondrocytes of wild-type skeletal ele-
ments (Figs. 5C, I), was also down-regulated (Figs. 5D, J) in
daCaMKII infected cells (Figs. 5B, H), while their expression
was not affected by kdCaMKII misexpression (data not shown).
Thus, misexpression of daCaMKII led to down-regulation of the
PPR-responsive genes Cyclin A and D1, and AP1 family mem-
bers, c-Fos and c-Jun in the majority of daCaMKII infected
cells. In contrast, ectopic expression of Ihh and ColX was only
detected in a subset of the infected chondrocytes and interest-
ingly never in the articular regions.
DaCaMKII accelerates chondrocyte maturation in vitro
To independently confirm the cell-autonomous effects of
CaMKII activation in vitro we used sternal primary chondrocyteFig. 5. CaMKII signaling causes down-regulation of the AP1 genes, c-Fos and
c-Jun. (A–L) Double fluorescent hybridizations on sections of the contra-lateral
ulna (A, C, E, G, I, K) of daCaMKII-infected specimens (B, D, F, H, J, K) at day
9.5, showing the distal end of the ulnae. (A, B) Cy5 channel detecting absence of
ectopic CamkII expression in the contra-lateral element (E) and ectopic
expression in infected elements (F) using a biotin-labeled anti-sense riboprobe.
(C, D) Cy3 channel showing ubiquitous c-Fos expression in proliferating
chondrocytes in wild-type (C) and patchy down-regulation in daCaMKII-
infected elements (yellow encircled areas in panel D) using a digoxygenin-
labeled anti-sense riboprobe. (E, F) Merged images showing CamkII in red and
c-Fos expression in green. (G, H) Cy5 channel detecting absence of ectopic
CamkII expression in the contra-lateral element (G) and ectopic expression in
the infected elements (L) using a biotin-labeled anti-sense riboprobe. (I, J) Cy3
channel showing ubiquitous c-Jun expression in proliferating chondrocytes in
the wild-type (I) and patchy down-regulation of c-Jun in daCaMKII-infected
elements (yellow encircled areas in panel J) using a digoxygenin-labeled anti-
sense riboprobe. (K, L) Merged images showing CamkII in red and c-Jun
expression in green.cultures, which were infected either with RCAS-Gfp, or RCAS-
daCaMKII-Gfp, or RCAS-kdCaMKII-Gfp virus. Chick caudal
(lower) sternal chondrocytes are a population of poliferative,
undifferentiated, immature chondrocytes that do not sponta-
neously proceed toward a terminal differentiation stage
(Gerstenfeld et al., 1990; Szuts et al., 1998). Retroviruses
carrying Gfp-fusion proteins of the mutated forms of CaMKII
were used in order to enrich for the infected chondrocytes by
sorting, since infections with untagged virus constructs resulted
only in 25–35% infected chondrocytes (based on immunohis-
tochemical stainings using an anti-gag-AB; data not shown).
Fig. 6. CaMKII-induced alteration in gene expression in cultured chondrocytes.
Bar diagram showing relative expression levels of the markers CyclinA, Cy-
clinD1, c-Jun, Ppr, ColX, Pthrp and Ihh by real-time PCR analyses using total
RNA isolated from sorted primary chicken sternal chondrocytes infected with
the experimental virus RCAS-daCaMKIIeGFP (red bars) or the control viruses,
RCAS-eGFP (blue bars) and RCAS-kdCaMKIIeGFP (yellow bars). Relative
expression levels of CyclinA (pb0.05), CyclinD1 (pb0.05), c-Jun (pb0.05),
Pthrp (pb0.2) were reduced by approximately 50%, while Ppr (pb0.05),
ColX (pb0.05) and Ihh (pb0.1) levels were approximately doubled in the
daCaMKIIeGFP-infected cells. Error bars represent the standard deviation of the
mean of the results (n= 4). Statistical significant changes in the expression levels
are indicated by the asterisk.
140 M.J. Taschner et al. / Developmental Biology 317 (2008) 132–146Similar infection rates were observed with the Gfp-fusion
viruses (data not shown). The relative expression level changes
of CyclinA, CyclinD1, c-Jun, Ppr, Ihh, ColX and Pthrp within
the Gfp-sorted, infected cells were determined by real-time PCR
analysis (Fig. 6). Relative expression levels of CyclinA, Cy-
clinD1, and c-Jun were reduced by 50% in the daCaMKII
infected cells, compared to control infected cells (RCAS-Gfp or
RCAS-kdCaMKII-Gfp). Interestingly, Pthrp expression levels
were also reduced by about 50% in daCaMKII infected cells. In
contrast, relative expression levels of the maturation markers
Ihh and ColX were increased in chondrocytes with activated
CaMKII-signaling. Furthermore, we observed an increase in the
relative expression level of Ppr in daCaMKII-infected cells, a
gene expressed at its highest levels within the prehypertrophic/
hypertrophic chondrocytes (Vortkamp et al., 1996). Thus, up-
regulation of Ihh, Ppr and ColX expression levels in daCaMKII
chondrocytes reflect a maturation of the infected chondrocytes
into prehypertrophic and hypertrophic chondrocytes, which is
in agreement with the in ovo observations where daCaMKII
infected chondrocytes ectopically matured. Furthermore, the in
vitro results confirmed that the accelerated maturation is a cell-
autonomous effect of CaMKII-signaling. Like in the in ovo
experiments, infection of primary chondrocytes with the
kdCaMKII-virus had no significant effect on the relative
expression levels of the genes analyzed (Figs. 6).
Overexpression of the inhibitor CaM-K2N results in shortened
long bones
In order to address the question whether endogenous
CaMKII signaling is involved in chondrocyte maturation we
overexpressed a retrovirus encoding the CaM-K2N peptide,which has been shown to act as a specific CaMKII inhibitor
(Chang et al., 1998, 2001). Misexpression of CaM-K2N
resulted in a consistent shortening of skeletal elements of the
infected wing by 4–17% (Figs. 7A,B). Marker analyses by in
situ hybridization on sections of day 9.5 old limbs revealed that
chondrocyte maturation was delayed in the infected skeletal
elements (Fig. 7C). In the infected ulnae the ColX expression
domains were not as far separated from each other as in the
contra-lateral control ulna. Similarly the Ihh expression
domains were closer together (length of the red bars com-
pared to the black bars in Fig. 7C). Thus, our data show that
inhibition of CaMKII signaling leads to an overall delay of
chondrocyte maturation suggesting that endogenous CaMKII-
signaling is normally involved in the positive regulation of
this process.
Discussion
CaMKII acts as a holoenzyme complex and is well known for
its roles in the nervous system and heart (Braun and Schulman,
1995; Elgersma et al., 2004; Soderling et al., 2001). CaMKII is
activated in response to increased intracellular calcium levels,
acting downstream of voltage-sensitive Ca2+ channels, ligand-
gated receptors and receptors activating phospholipase C (PLC).
Studying the biological function of CaMKII has been difficult,
given that CaMKII is ubiquitously present in every cell and that
the holoenzyme complex can be comprised of different isoforms
encoded by four independent genes. Thus, to study its functional
requirement in vitro chemical inhibitors have often been used.
Here we used a retroviral overexpression system in the chick and
demonstrate that CaMKII-signaling is playing a role in
chondrocyte maturation.
CaMKII activation causes premature maturation of infected
chondrocytes
In chick various splice-variants of all four CamkII isoforms,
α, β, γ and δ, are expressed in chondrocytes. Here we showed
that retroviral mediated expression of a constitutively active
form of CaMKII resulted in premature maturation of chon-
drocytes at ectopic locations in a cell-autonomous manner.
However, not all of the infected chondrocytes within the
proliferative zone differentiated ectopically into mature chon-
drocytes, this was particularly obvious in the articular most
regions. Furthermore, ectopic Ihh expressing cells were always
found closer to the epiphyseal regions, while ectopic ColX
positive chondrocytes were always observed farther away from
the articular ends. This resembles the normal maturation
program, whereby chondrocytes cease to proliferate and start
to express Ihh before they up-regulate the hypertrophic marker
ColX. These observations suggest that the maturation process in
ectopically differentiating chondrocytes is probably still under
the control of additional factors, which are either intrinsic or
extrinsic. Based on the results from the in vitro experiments we
favor intrinsic factors. However, we can not rule out the
possibility that in vivo extrinsic factors oppose the CaMKII
dependent acceleration of chondrocyte maturation, especially
Fig. 7. Inhibition of endogenous CaMKII activity results in shortening of skeletal elements and delayed chondrocyte maturation. (A) Alcian blue stained whole skeletal
preparations of a wing pair at d9.5; showing a shortening of the lower right (R) RCAS-CaM-K2N infected wing in comparison to the upper contra-lateral left (L)
uninfected wing. The black bars and the numbers indicate the length of the ulna; note length of the uninfected L-wing is set to one. (B) Bar diagram showing the
relative length of the CaM-K2N infected ulnae (black bar) in comparison to the length of the ulnae of the contra-lateral wing (orange bar). Error bar represents the
standard deviation of the mean of the results, pb0.0003 (paired Student t-test). (C) Non-radioactive in situ hybridizations on alternating sections of a day 9.5
uninfected contra-lateral and the CaM-K2N-infected ulna using digoxygenin-labeled anti-sense riboprobes for CaM-K2N, ColX and Ihh. CaM-K2N staining shows
the absence of infection in the contra-lateral ulna, the rate of infection in the infected ulna. ColX staining shows that the expression domains are closer together in the
infected ulna (red bar compared to black bar). The Ihh staining shows that the Ihh expression domains are closer together in the infected ulna (red bar compared to black bar).
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up-regulates maturation markers. The phenotype we observed
in the mosaic growth plates of chicken long bones, where cells
expressing the constitutively active form of CaMKII are
intermingled with non-infected wild type cells, remarkably
resembles the phenotype observed in Ppr−/− chimeric growth
plates where Ppr deficient chondrocytes located within the
proliferative zone of otherwise wild-type chondrocytes ectopi-
cally mature into prehypertrophic/hypertrophic chondrocytes
(Chung et al., 1998, 2001).
Our attempt to inhibit the endogenous CaMKII activity in
skeletal elements by overexpression of a specific inhibitory
peptide resulted a slight, but statistically significant, shortening
of the infected skeletal elements and was associated with
delayed chondrocyte maturation. The delay is reflected in the
observations that the Ihh positive zones of prehypertrophic and
the ColX positive zones of hypertrophic chondrocytes are closer
together than in the contra-lateral control element. This
phenotype is similar to the one observed in mouse expressing
a mutant form of PPR, which cannot activate phospholipase C
(Guo et al., 2002).DaCaMKII retroviral expression causes non-cell autonomous
phenotypes
Retroviral misexpression of growth factors or signaling
modifiers very often leads to shortening of infected skeletal
elements, while lengthening of the long bones has only been
observed in a few cases. In particular, mice lacking the Fgfr3, or
mice with too high levels of Insulin-like growth factor 1 (IGF1),
or increased C-type natriuretic peptide (CNP) signaling activity
have elongated long bones (Colvin et al., 1996; Jaubert et al.,
1999; Mathews et al., 1988). Interestingly, overexpression of
daCaMKII also resulted in an overall elongation in length of the
infected skeletal elements. This elongation is the complex result
of a combination of cell-autonomous and non-cell-autonomous
effects. The acceleration of chondrocyte maturation is a cell-
autonomous effect of activated CaMKII signaling and is
associated with two non-cell autonomous effects, elongation
of the proliferative zone and delay of hypertrophic chondrocyte
maturation. The latter two effects are due to the cell-
autonomous acceleration of chondrocyte maturation resulting
in ectopic differentiation of Ihh expressing chondrocytes closer
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lengthening of skeletal elements by two mechanisms. First, it
serves as a direct proliferative stimulus for the surrounding
chondrocytes due to the proliferation promoting activity of
IHH, acting independently of PTHrP (Karp et al., 2000). This
activity is probably reflected in the observed up-regulation of
CyclinD1 in cells outside of the infected regions, since Cy-
clinD1 has recently been shown to be a direct target of IHH
signaling (Long et al., 2001). Second, ectopic expression of Ihh
also led to an up-regulation of PTHrP, an IHH responsive factor,
in articular chondrocytes thereby keeping chondrocytes in the
proliferative pool. In addition to IHH, the increase in PTHrP
signaling could be responsible for the up-regulation of Cy-
clinD1. Since we did not observe a distinct up-regulation of the
expression of CyclinA, c-Fos or c-Jun, which presumably are
also regulated by PTHrP-signaling, we favor the hypothesis that
the up-regulation of CyclinD1 is an effect of IHH signaling. As
a consequence the proliferative zone of chondrocytes is
enlarged in the infected skeletal elements in a non-cell
autonomous manner due to the combination of PTHrP-
independent and -dependent activities of IHH, acting on the
non-infected pool of chondrocytes. The two effects, increased
proliferation and higher PTHrP levels, which keep cells within
the proliferative pool, have been previously shown to delay
chondrocyte maturation (Vortkamp et al., 1996; Weir et al.,
1996). Therefore, those activities are eventually responsible for
the observed non-cell autonomous delay in the maturation of
hypertrophic, ColX expressing chondrocytes in the early (day
7.5) daCaMKII infected skeletal elements. In contrast, down-
regulation of Cyclin A and D1, c-Jun, and c-Fos, as well as
the up-regulation of ColX, Ihh and Ppr observed in vivo and
in vitro are cell-autonomous effects of activated CaMKII
signaling.
Surprisingly, in vitro Pthrp expression was down-regulated
in the infected chondrocytes unlike in ovo where Pthrp
expression in articular chondrocytes was increased. This can
be explained by the differences in chondrocyte populations in
vitro versus in ovo. In the sternum, but also the long bones
Pthrp is expressed in proliferating chondrocytes as well and
becomes down-regulated in maturated chondrocytes (Pateder et
al., 2001, 2000). Thus, the down-regulation of Pthrp expression
in the cultures most likely reflects that these cells have
undergone maturation.
CaMKII signaling acts down-stream of PPR controlling
chondrocyte maturation
As mentioned earlier CaMKII can be activated in response to
different events, including signaling pathways mediated
through heterotrimeric G-protein coupled receptors or recep-
tor-tyrosine-kinases, which activate different PLC isoforms
(Schlessinger, 2004). Among the signaling pathways that lead
to PLC activation and possibly CaMKII are the non-canonical
Wnt-, the PTHrP/PPR- and Fgf-signaling pathway, all of which
have been implicated in regulating chondrocyte maturation
(Kronenberg, 2006; Ornitz and Marie, 2002; Yang et al., 2003).
Activation of non-canonical Wnts, such as Wnt5a and Wnt5b,delayed chondrocyte maturation in chick and mouse and did not
result in a down-regulation of CyclinD1 expression (Church et
al., 2002; Hartmann and Tabin, 2000; Yang et al., 2003). Fgf-
signaling has been shown to induce CyclinD1 expression and to
inhibit chondrocyte proliferation (Krejci et al., 2004; Zhang et
al., 2004). Furthermore, it has been suggested that Fgf-signaling
promotes chondrocyte maturation in part by down-regulation of
Ihh expression (Dailey et al., 2003; Minina et al., 2002).
However, this is controversial, since there is evidence that Fgf-
signaling positively regulates Ihh expression during early
skeletal development (Hung et al., 2007; Spater et al., 2006).
Based on our results we would rule out that CaMKII is acting
downstream of non-canonical Ca2+/Wnt-signaling that delays
chondrocyte maturation. However, CaMKII might still be
acting downstream of Fgfs mediating their positive effect on
chondrocyte maturation, but it is generally thought that Fgfs
exert their activities on chondrocytes via the MAPK-pathway
and Stat1 activation (Murakami et al., 2004; Raucci et al., 2004;
Sahni et al., 2001). This clearly needs to be investigated further
in the future, particularly, because Stat1 has been reported being
a CaMKII substrate (Nair et al., 2002).
Ectopic CaMKII activation led to an up-regulation of Ppr
expression in vivo and in vitro (Fig. 6, and data not shown).
Based on this observation we exclude the possibility that
ectopic maturation is due to transcriptional down-regulation of
Ppr levels in the infected chondrocytes, like it has been
observed in some PTH-responsive cell-lines (Fukayama et al.,
1994). Instead we favor the idea that CaMKII activity is
intracellularly interfering with the proliferation promoting
activity of PPR signaling and that it is acting downstream of
the PPR-Gq/11 signaling branch. This branch is thought to
stimulate chondrocytes maturation and to oppose the prolif-
erative branch acting via PKA (Guo et al., 2002). PPR has
been shown to activate via PKA and the cAMP-response
element binding protein (CREB) a number of genes, including
CyclinA and CyclinD1 (Beier et al., 2001; Beier and LuValle,
2002; Ionescu et al., 2001). Mice mutant for CyclinD1 are
growth retarded (Fantl et al., 1995; Sicinski et al., 1995). PPR
signaling also leads to an increase in c-Jun and c-Fos
expression (Kameda et al., 1997; McCauley et al., 1997),
which have been shown to inhibit chondrocyte maturation
(Kameda et al., 1997; Thomas et al., 2000; Watanabe et al.,
1997). Therefore, it is likely that the down-regulation of the
cyclins and AP1 family members is a necessary prerequisite
for chondrocyte maturation.
Active CaMKII can exert its effect on chondrocyte maturation
through a variety of mechanisms
There are numerous possibilities how CaMKII activity could
interfere with PPR/PKAmediated gene regulation. Downstream
of PPR, CREB transcriptional activity is supposedly stimulated
by phosphorylation of Ser133 mediated by PKA (Gonzalez and
Montminy, 1989). Interestingly, it has been shown that CaMKII
can also phosphorylate CREB in vitro (Sheng et al., 1991). The
phenotype observed in chondrocytes, however, suggests an in-
activation of CREB activity rather than stimulation. Peculiarly,
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CREB at Ser133 and Ser142, thereby preventing its dimeriza-
tion with the CREB binding protein (CBP) and subsequent gene
activation (Wu and McMurray, 2001). However, CREB levels
and CREB-pSer133 levels were not altered in extracts from
daCaMKII-infected chondrocytes compared to controls and we
could not detect CREB-Ser142 phosphorylation by Western
blot or immunohistochemistry using a phospho-Ser142 specific
antibody (data not shown).
Not only CREB, but also the activating transcription factor 2
(ATF2) and the retinoblastoma susceptibility gene product/Sp1
signaling pathway control the expression of Cyclins (A and
D1), and c-Fos and CyclinD1, respectively (Beier et al., 1999,
2000; Sohm et al., 1999). ATF2, like ATF1 or CREB, could be a
potential target for phosphorylation by CaMKII, leading to the
inhibition of its transcriptional activity (Sun et al., 1994, 1996).
Disruption of ATF2 activity, but also overexpression of a
dominant-negative form of CREB (A-CREB) in mice result in
chondrodysplasia, showing that members of this transcription
factor family are involved in chondrocyte differentiation (Beier
et al., 2000, 2001; Long et al., 2001; Reimold et al., 1996).
However, unlike the loss of PPR (Chung et al., 1998), neither
loss of ATF2 nor overexpression of A-CREB resulted in
premature differentiation of chondrocytes, suggesting that
CaMKII activation and PPR-signaling must have additional
effects.
Furthermore, CaMKII has been shown to inhibit Rb/Sp1
transcriptional activity through direct phosphorylation of Rb
and Sp1, leading to increased degradation and inhibiting DNA
binding activity, respectively, thereby affecting the transcription
of c-Fos and CyclinD1 (Sohm et al., 1999).
The cAMP-phosphodiesterase (PDE) has also been shown to
be a substrate of CaMKII in the central nervous system
(Yoshimura et al., 2000). Phosphorylation of cAMP-phospho-
diesterase can increase the activity of PDE (Macphee et al.,
1988; Shaulsky et al., 1998) and this could lead eventually to a
down-regulation of PKA activity. Inhibition of PKA activity has
been shown to lead to up-regulation of chondrocyte maturation
markers such as Runx2 and subsequent activation of Runx2
target genes such as Ihh and ColX (Li et al., 2004; Takeda et al.,
2001; Yoshida et al., 2004; Zheng et al., 2003). Active CaMKII
signaling could further stimulate hypertrophy by increasing
either Runx2 or Mef2c activity through inhibition of their co-
repressor HDAC4 by phosphorylation (Arnold et al., 2007;
Linseman et al., 2003; Little et al., 2007; Vega et al., 2004).
Inhibition of HDAC4 could be directly through HDAC4
phosphorylation or indirectly through 14-3-3 phosphorylation
by CaMKII (Ellis et al., 2003; Little et al., 2007). The exact
mechanism how activated CaMKII signaling promotes chon-
drocyte maturation will be subject of future investigations.
Unfortunately, our study did not allow us to determine which
CaMKII-isoform(s) are the relevant ones. Although our data
suggest that activation of CaMKII signaling has multiple
potential targets and differential phenotypic effects in chon-
drocytes, the overexpression of the activated CaMKIIα-isoform
could potentially not only lead to a change in total CaMKII
activity, but might affect the subcellular activity of differentCaMKII holoenzyme complexes within the cell, which might
have different targets (Hudmon and Schulman, 2002). Despite
these potential limitations, our gain- and loss of function
overexpression data suggest that CaMKII signaling is involved
in chondrocyte differentiation.
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